These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
492 related items for PubMed ID: 26191151
1. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis. dos Santos M, Bringhenti RN, Rodrigues PG, do Nascimento JF, Pereira SV, Zancan R, Monticielo OA, Gasparin AA, de Castro WP, Veronese FV. Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151 [Abstract] [Full Text] [Related]
2. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis. Perez-Hernandez J, Olivares MD, Forner MJ, Chaves FJ, Cortes R, Redon J. Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688 [Abstract] [Full Text] [Related]
3. Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies. Rodrigues PG, Bringhenti RN, do Nascimento JF, Joelsons G, dos Santos M, Pereira S, Veronese FV. Int J Clin Exp Pathol; 2014 May; 7(5):2185-98. PubMed ID: 24966927 [Abstract] [Full Text] [Related]
4. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis. Nawata A, Hisano S, Shimajiri S, Wang KY, Tanaka Y, Nakayama T. Histopathology; 2018 Jun; 72(7):1084-1092. PubMed ID: 29247494 [Abstract] [Full Text] [Related]
5. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients. Ma R, Jiang W, Li Z, Sun Y, Wei Z. Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620 [Abstract] [Full Text] [Related]
6. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis. Avihingsanon Y, Phumesin P, Benjachat T, Akkasilpa S, Kittikowit V, Praditpornsilpa K, Wongpiyabavorn J, Eiam-Ong S, Hemachudha T, Tungsanga K, Hirankarn N. Kidney Int; 2006 Feb; 69(4):747-53. PubMed ID: 16518330 [Abstract] [Full Text] [Related]
7. Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis. Wang G, Lai FM, Tam LS, Li KM, Lai KB, Chow KM, Li KT, Szeto CC. J Rheumatol; 2007 Dec; 34(12):2358-64. PubMed ID: 17985404 [Abstract] [Full Text] [Related]
8. Urine podocyte mRNAs mark disease activity in IgA nephropathy. Fukuda A, Sato Y, Iwakiri T, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S. Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757 [Abstract] [Full Text] [Related]
9. The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study. Yuan M, Tan Y, Wang Y, Wang SX, Yu F, Zhao MH. Lupus; 2019 Mar; 28(3):347-358. PubMed ID: 30755145 [Abstract] [Full Text] [Related]
10. [The significance of urinary podocytes in patients with active lupus nephritis]. Li JZ, Liu Y, E J, Huang HC, Yu F, Zou WZ, Wang HY. Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):127-30. PubMed ID: 17445439 [Abstract] [Full Text] [Related]
11. Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria? Rezende GM, Viana VS, Malheiros DM, Borba EF, Silva NA, Silva C, Leon EP, Noronha IL, Bonfa E. Lupus; 2014 Mar; 23(3):255-62. PubMed ID: 24356611 [Abstract] [Full Text] [Related]
12. Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology. Perysinaki GS, Moysiadis DK, Bertsias G, Giannopoulou I, Kyriacou K, Nakopoulou L, Boumpas DT, Daphnis E. Lupus; 2011 Jul; 20(8):781-91. PubMed ID: 21478284 [Abstract] [Full Text] [Related]
13. Increased urine podocyte-associated messenger RNAs in severe obesity are evidence of podocyte injury. Pereira SV, Dos Santos M, Rodrigues PG, do Nascimento JF, Timm JR, Zancan R, Friedman R, Veronese FV. Obesity (Silver Spring); 2015 Aug; 23(8):1643-9. PubMed ID: 26147062 [Abstract] [Full Text] [Related]
14. Value of immunohistochemical expression of podocalyxin in active lupus nephritis. Behairy MA, Shakweer MM, El Said TW, ElGharbawy NH. Nefrologia (Engl Ed); 2018 Aug; 38(1):64-72. PubMed ID: 28757276 [Abstract] [Full Text] [Related]
15. Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response. Wang G, Lai FM, Tam LS, Li EK, Kwan BC, Chow KM, Li PK, Szeto CC. Rheumatology (Oxford); 2009 Jul; 48(7):755-60. PubMed ID: 19458162 [Abstract] [Full Text] [Related]
16. Urine podocyte mRNAs mark progression of renal disease. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, Chang JW, Wiggins JE, Lienczewski C, Kretzler M, Wiggins RC. J Am Soc Nephrol; 2009 May; 20(5):1041-52. PubMed ID: 19389856 [Abstract] [Full Text] [Related]
17. Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases? Lopes TG, de Souza ML, da Silva VD, Dos Santos M, da Silva WIC, Itaquy TP, Garbin HI, Veronese FV. PLoS One; 2019 May; 14(6):e0217585. PubMed ID: 31220088 [Abstract] [Full Text] [Related]
18. Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus. Lu J, Hu ZB, Chen PP, Lu CC, Zhang JX, Li XQ, Yuan BY, Huang SJ, Ma KL. BMC Nephrol; 2019 Aug 05; 20(1):303. PubMed ID: 31382919 [Abstract] [Full Text] [Related]
19. Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis. Avihingsanon Y, Benjachat T, Tassanarong A, Sodsai P, Kittikovit V, Hirankarn N. Kidney Int; 2009 Jun 05; 75(12):1340-1348. PubMed ID: 19295501 [Abstract] [Full Text] [Related]
20. Urinary podocytes for the assessment of disease activity in lupus nephritis. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H. Am J Med Sci; 2000 Aug 05; 320(2):112-6. PubMed ID: 10981486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]